Common TitleHPTN 084-1 (Adolescents-LIFT Study)
Official Title Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV among Adolescent Females – A Sub-study of HPTN 084
Phase Phase IIB
Treatments
Cabotegravir
Cabotegravir
Tradename:ApretudeOther Names:Injectable cabotegravir, Long-acting injectable cabotegravirClass:Integrase Inhibitors (INSTI)Funding
IndustryViiV Healthcare
Non-IndustryNational Institute of Allergy and Infectious Diseases